Skip to main content

Sam Semenko

Analyst

Citi

Equibles does not estimate personal net worth.

About Sam Semenko

Sam Semenko is recorded as Analyst at Citi. Sam Semenko has spoken on 3 investor events across 3 companies, most recently for Roivant Sciences Ltd. on September 10, 2026. Those appearances were for Roivant Sciences Ltd. (ROIV), Dianthus Therapeutics, Inc. /DE/ (DNTH) and Allogene Therapeutics, Inc. (ALLO). The companies whose calls Sam Semenko spoke on are classified in the Healthcare sector.

Sam Semenko on recent calls

“I'm joined by Richard Paluk, CFO of Roy Vant. Richard, welcome and thank you so much for being here.”
Analyst — Citi, Citi - 2026 Biopharma Conference ·
“I'm joined by Marina Garcio, CEO of Dianthus. Marina, welcome, and thank you so much for being here.”
Analyst — Citi, Citi's 2026 Biopharma Back to School Conference ·
“I'm joined this morning with Zach Roberts, president and CEO of Allogene. Zach, welcome, and thank you so much for being here.”
Analyst — Citi, Citi Biopharma Back to School Conference ·

Affiliation history

  • Citi

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity